Mobile application
2 papers4 findings
- 1 lab in 1 country
- Funders: National Institute on Aging and 3 more
- Human trial2
Outcomes
4Normoglycemia
upin humans1
1 study
Normoglycemia
upin humans1
Mobile application increases normoglycemia in humans (17.2% vs 6%).
“11 participants (17.2%) in the application group reversed to normoglycemia, compared to, 4 participants (6%) in the standard care group.”
Human trial6 months
ENDO 2025 abstract22 Oct 2025
Body weight
downin humans1
1 study
Body weight
downin humans1
Mobile application decreases body weight in humans.
“The changes in bodyweight, waist circumference, and HbA1C between groups were significantly different at 6 months between the groups”
Human trial6 months
ENDO 2025 abstract22 Oct 2025
HbA1c
downin humans1
1 study
HbA1c
downin humans1
Mobile application decreases HbA1c in humans.
“The changes in bodyweight, waist circumference, and HbA1C between groups were significantly different at 6 months between the groups”
Human trial6 months
ENDO 2025 abstract22 Oct 2025
Fasting plasma glucose
no changein humans1
1 study
Fasting plasma glucose
no changein humans1
Mobile application has no effect on fasting plasma glucose in humans (mean difference -2.60 mg/dL [95% CI -5.73, 0.52], p=0.102).
“there is no difference in FPG (mean difference -2.60 mg/dL [95% CI -5.73, 0.52], p=0.102).”
Human trial6 months
ENDO 2025 abstract22 Oct 2025
Funding
4 grants since 2016National Institute on AgingUS$455kAmerican Heart AssociationUS$1mCanadian Institutes of Health Research (CIHR) Project GrantCA$2k
Latest
1 in 12 monthsDiabetes, Obesity & Metabolism
An Evening Activity Breaks Intervention for Improvement of Glucose, Blood Pressure, and Sleep: A Pilot Study in Free-Living Adults
Non-randomised trial in 20 peopleInterventions
ENDO 2025 Abstract
SUN-569 The Efficacy of Mobile Application on Diabetes Prevention Compared with Standard of Care in Adults with Prediabetes: Randomized Controlled Trial
Randomised trial in 131 peoplePrediabetes